Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @biofourmis
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @biofourmis
-
Our CEO and founder
@ksingh_rajput will be speaking at the Forbes Healthcare Summit 2019 in New York on 5th December 2019. He will be joined on the panel by@GlenTullman and@KentuckyChang, moderated by@TheAlexKnapp.#biofourmis#biovitals#biotech#digitaltherapeuticshttps://twitter.com/ksingh_rajput/status/1200027584517439489 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Once BiovitalsHF™ receives FDA approval,
@biofourmis would be able to communicate recommendations directly to patients, skipping labor intensive manual phone calls and hospital visits." -@ksingh_rajput on@moneyfm893https://omny.fm/shows/money-fm-893/health-suites-revolutionising-cardiovascular-healt …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Biofourmis' founder and CEO Kuldeep Singh Rajput spoke at the Festival of Ideas by LKYSPP about tech as a force of good in healthcare provision. Read his key takeaways here:https://twitter.com/ksingh_rajput/status/1197837471452581888 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@biofourmis' Founder and CEO Kuldeep Singh Rajput (@ksingh_rajput) will be talking about the recently announced Novartis alliance and the missing link in modern healthcare with@moneyfm893 at 3:35pm SGT. Tune in here: https://www.moneyfm893.sg/#biofourmis#biotech#biovitalsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BREAKING NEWS x 2: (1) We've acquired
@Biovotion, adding the Everion#wearable + 60 global patents to our#DigitalTherapeutics ecosystem (2) We've signed a major commercial deal and rollout with@Novartis starting this month.@biofourmishttps://medcitynews.com/2019/11/massachusetts-based-biofourmis-firm-to-acquire-zurich-wearable-company/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Biofourmis is thrilled to share the news that FDA approval has been received for our machine-learning and AI powered#Biovitals™ Analytics Engine as a medical device for ambulatory physiological monitoring.#FDAapproval#digitaltherapeuticshttps://tinyurl.com/y3zuv883Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today
#Biofourmis CEO Kuldeep Singh Rajput spoke at the#CBInsights Future of Health conference in NY on our work enabling clinical interventions through predictive#digitaltherapeutics. Honored to be on the 2019 Digital Health 150 List of Most Innovative Digital Health StartupsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Moving our Global HQ to Boston was a great move for Biofourmis; talent and innovation both inspire and drive us. Our team in Boston is already 20 strong and we are looking to nearly double this by the end of 2019. https://fivethirtyeight.com/sponsored/massachusetts-biotech/ …
#biofourmis#biotechHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On Friday our Founder and CEO
@ksingh_rajput was speaking at the@MilkenInstitute Asia Summit on a panel called Perfection precision health: personalizing medicine for all. Precision health is dramatically reshaping the landscape of health and care.#MIGlobal#Biofourmispic.twitter.com/NlzN33upxQHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In 3 years
#Biofourmis has grown to 50 employees in Singapore with plans to scale to 70+ by the end of 2019. Our new office space provides a fresh and vibrant environment for our team to problem solve and generate new ideas in a nurturing workspace.#newoffice#growthpic.twitter.com/YUS6KstdZM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to partner with
@Yale@MayoClinic CERSI and@US_FDA CDER to use@biofourmis'#BiovitalsHF platform to measure patient-centric endpoints to inform future drug development, potentially shorten approval times!https://www.fiercebiotech.com/biotech/fda-contributes-to-hunt-for-new-heart-failure-endpoints …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to partner with
#Jianke to use our lead product#BiovitalsHF to manage ~10 Million Heart Failure patients in China!@SCMPNews#digitaltherapeutics#AI#heartfailure#cardiologyhttps://www.scmp.com/business/companies/article/3013621/foreign-start-ups-eye-chinas-vast-digital-health-care-market …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The application of
#MachineLearning are potentially limitless, being able to predict and prevent serious medical events! Thanks to@Forbes for counting us as one of the 20 Machine Learning startups' to watch in 2019!#digitaltherapeutics#AI#MLhttps://www.forbes.com/sites/louiscolumbus/2019/05/27/25-machine-learning-startups-to-watch-in-2019/#6fb579b93c0b …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It’s official! we’ve closed our US$35mn series B round led by
@sequoia and co-led by@MMVboston!@EDBsg, Jianke, and all existing investors participated in the round!@DTx#digitalhealth#AI#SeriesBhttps://www.mobihealthnews.com/content/ai-enabled-monitoring-decision-support-platform-biofourmis-raises-35m …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are thrilled to announce that our AI-based cloud-based software platform RhythmAnalytics has been cleared by the
@US_FDA to detect over 15 types of cardiac arrhythmias! https://www.businesstimes.com.sg/garage/biofourmiss-software-to-detect-irregular-heartbeat-gets-us-fda-clearance … …#digitaltherapeutics#biofourmis#Cardiology#FDA#MIGlobal#MIYLC#AIpic.twitter.com/JufZcGiqCs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CEO and Co-Founder
@ksingh_rajput was recently honoured with an invitation to join@MilkenInstitute's Young Leader's Circle (YLC)!#MIGlobal#YLC#MilkenInstitute#YoungLeadersCirclepic.twitter.com/gR3xCVPV7x
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're proud to say that our deep learning platform for ECG interpretation, RhythmAnalytics, outperforms a human analysis of an ECG with a high degree of accuracy! Read the full paper here: https://arxiv.org/abs/1904.00138
#Biofourmis#DeepLearning#AI#Cardiology#HealthTechpic.twitter.com/fl7kTavmgp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to our Founder and CEO
@ksingh_rajput for making it into the@ForbesAsia 30 Under 30 list for Healthcare and Science 2019! https://www.forbes.com/under30/list/2019/asia/healthcare-science/#7c78fae6c98a …#Biofourmis#ForbesU30Asia#ForbesUnder30pic.twitter.com/DxbN91frix
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're excited to work with
@American_Heart to deliver personalized software-based intervention, coupled with the health education content and care pathways in managing heart failure patients.@mdmajmudar@biofourmis#digitaltherapeutics#heartfailure https://www.marketwatch.com/press-release/biovitalshftm-a-prescription-software-uses-data-science-to-augment-guideline-directed-use-of-heart-failure-therapies-2019-03-13 …pic.twitter.com/RTk3DwjSYC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Biofourmis proslijedio/la je Tweet
Harnessing the power of AI to advance the practice of medicine
@biofourmis#personalizedmedicinepic.twitter.com/mwssOgGugx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.